Anzeige
❌
Mehr »
Freitag, 30.10.2026 - Börsentäglich über 12.000 News
Tiefsee-Explorer bricht Chinas Kobalt-Monopol
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PAJG | ISIN: CNE100003F19 | Ticker-Symbol: WX8
Tradegate
28.10.26 | 14:44
21,765 Euro
+0,51 % +0,110
1-Jahres-Chart
WUXI APPTEC CO LTD Chart 1 Jahr
5-Tage-Chart
WUXI APPTEC CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
21,05021,34011:43
21,07021,32011:44

Aktuelle News zur WUXI APPTEC Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
WUXI APPTEC Aktie jetzt für 0€ handeln
DoDaiwa Slightly Raises WUXI APPTEC TP to HKD232 as 3Q Results Beat Expectations Again2
MiCiti Raises WUXI APPTEC TP to HKD240, Maintains Buy Rating11
MiG Sachs Raises WUXI APPTEC TP to HKD251, Upgrades Earnings Forecasts on Stronger Confidence for Next Year4
MiJPM Raises WUXI APPTEC TP to HKD233 as Geopolitical Risks Ease3
DiWuXi AppTec bucks DOD uncertainty through Q3, lifting forecast for 20262
DiG Sachs: WUXI APPTEC 3Q Results Solid, Raises Guidance Again; Visibility for Growth Next Year Improves2
DiCLSA: WUXI APPTEC 3Q Results in line; Reiterates 'Outperform' Rating3
DiCiti: WUXI APPTEC TIDES and Order Backlog Grow Strongly2
MoWuXi AppTec Non-GAAP EPS of RMB 6.21, revenue of RMB 45.54B; rasies full-year guidance4
MoWuXi AppTec Delivers Strong Q1-Q3 2026 Results and Further Raises Full-Year Guidance, Driven by Greater Success of Multiple Customers' Products and CRDMO Model172SHANGHAI, Oct. 26, 2026 /PRNewswire/ -- WuXi AppTec (Stock Codes: 603259.SH / 2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and...
► Artikel lesen
MoWuXi AppTec Co., Ltd. Nine Months Income Advances3
MoWUXI APPTEC 1Q-3Q Net Profit Up 62.4% YoY; Further Raises Full-year Guidance5
MoWUXI APPTEC (02359): 2026 THIRD QUARTERLY REPORT1
23.10.WuXi AppTec: How Peptide Conjugate Developability Is Shaped Before a Candidate Is Nominated10
21.10.WuXi AppTec: Peptide Manufacturing Trends: How Oral Dosing Raises API Demand4
20.10.Frost & Sullivan awards WuXi AppTec with 2026 Global Company of the Year Recognition for CRDMO Leadership639Frost & Sullivan awards WuXi AppTec with 2026 Global Company of the Year Recognition for CRDMO Leadership Integrated capabilities, global capacity, and customer-centric innovation strengthen WuXi...
► Artikel lesen
12.10.WUXI APPTEC (02359): DATE OF BOARD MEETING3
06.10.HSI Closes at 24,280, Up 240 pts; HSTI Closes at 4,223, Up 39 pts; J&T EXPRESS-W Up over 5%; WUXI BIO, WUXI APPTEC, GENSCRIPT BIO Hit New Highs2
02.10.WUXI APPTEC: AI Drug R&D Still In Exploration Stage; CXO Empowerment Needed to Build Industry Closed Loop6
30.09.HSI Closes at 24,613, Up 89 pts; HSTI Closes at 4,253, Up 4 pts; CSPC PHARMA Up over 6%; WUXI BIO, WUXI APPTEC, GENSCRIPT BIO, H&H INTL HLDG Hit New Highs; Market Turnover Rises16
1 2 3 4 5 Weiter >>
85 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1